19 épisodes

We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, Webinars, and podcasts at: https://www.impactmedicom.com.

IMPACT Medicom IMPACT Medicom

    • Sciences

We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, Webinars, and podcasts at: https://www.impactmedicom.com.

    Precision Medicine in Oncology: Ep.5 Precision medicine for metastatic colorectal cancer

    Precision Medicine in Oncology: Ep.5 Precision medicine for metastatic colorectal cancer

    In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:
    ·       The current standards for molecular testing in metastatic colorectal cancer
    ·       The potential benefit of a Canadian guideline for molecular testing in metastatic colorectal cancer
    Our guest:
    Dr. Sharlene Gill is Professor of Medicine at the University of British Columbia and Medical Oncologist at BC Cancer in Vancouver. Dr. Gill earned her MD from the University of British Columbia and completed a fellowship in gastrointestinal oncology at the Mayo Clinic (Rochester, MN). She also received a Master of Public Health degree from the Harvard School of Public Health and completed her MBA at the Kenan-Flagler School of Business at the University of North Carolina. Dr. Gill currently specializes in the treatment of gastrointestinal malignancies and serves as the Chair of the Canadian Clinical Trials Group GI Disease Site Committee. In addition, she is President-Elect of the Canadian Association of Medical Oncologists and is Editor-in-Chief for the peer-reviewed journal Current Oncology.
     
    This podcast episode was sponsored by Merck Canada.
     
    If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com 

    • 22 min
    Lung Cancer Screening: Western Canada

    Lung Cancer Screening: Western Canada

    Background
    Lung cancer is one of the most common cancers and is the leading cause of cancer death in Canada. (2020 Canadian Cancer Statistics) Survival from lung cancer is poor. Three-year net survival for lung cancer decreased from 71% among those diagnosed at stage 1 to 5% among those diagnosed at stage 4. Approximately half of all lung cancer cases in Canada are stage 4 at diagnosis. (2020 Canadian Cancer Statistics) Two clinical trials, the Dutch-Belgian screening trial (NELSON) and the United States National Lung Screening Trial (NLST), have demonstrated the value of lung cancer screening in reducing mortality rates in high-risk populations. The lung cancer community across Canada is therefore united in the belief that screening programs should be implemented nationwide. Lung Cancer Screening programs have been announced across Canada. The Ontario program launched in April 2021 and the program in Quebec launched in June 2021. A program in BC was announced in 2020 and will launch in the near future. Other provinces across Canada are working on developing screening programs also. In this podcast series, we discuss the importance of lung cancer screening and aim to raise awareness of these programs in Canada in order to improve patient care. Our Guests
    Dr. Stephen Lam: Professor of Medicine at the University of British Columbia and Medical Oncologist at BC Cancer. Dr. Lam is a Distinguished Scientist, and Leon Judah Blackmore Chair in Lung Cancer Research at the BC Cancer Research Center. He was the recipient of the Friesen-Rygiel Award for Outstanding Canadian Academic Discovery and the Gustav Killian Medal by the World Association of Bronchology for his pioneering contributions to the field of early lung cancer diagnosis, the Distinguished Achievement Award from the University of British Columbia and the Joseph Cullen Award for life-time scientific achievements in lung cancer prevention research by the International Association for the Study of Lung Cancer. 
    Dr. Rakesh Patel: General practitioner from Silverado Medical Clinic in Calgary, Alberta.

    Resources
    BC Press release http://www.bccancer.bc.ca/about/news-stories/news/2020/b-c-launches-lung-cancer-screening-program-%E2%80%93-the-first-in-canada

    CPAC Report: https://s22457.pcdn.co/wp-content/uploads/2021/01/lung-cancer-screening-environmental-scan-2019-2020-Jan132021-EN.pdf
    TO FIND A SCREENING PROGRAM NEAR YOU: https://right2survive.ca/resource-centre/screening/
     If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.

    • 25 min
    Lung Cancer Screening: Ontario

    Lung Cancer Screening: Ontario

    Background
    Lung cancer is one of the most common cancers and is the leading cause of cancer death in Canada. (2020 Canadian Cancer Statistics) Survival from lung cancer is poor. Three-year net survival for lung cancer decreased from 71% among those diagnosed at stage 1 to 5% among those diagnosed at stage 4. Approximately half of all lung cancer cases in Canada are stage 4 at diagnosis. (2020 Canadian Cancer Statistics) Two clinical trials, the Dutch-Belgian screening trial (NELSON) and the United States National Lung Screening Trial (NLST), have demonstrated the value of lung cancer screening in reducing mortality rates in high-risk populations. The lung cancer community across Canada is therefore united in the belief that screening programs should be implemented nationwide. Lung Cancer Screening programs have been announced across Canada. The Ontario program launched in April 2021 and the program in Quebec launched in June 2021. A program in BC was announced in 2020 and will launch in the near future. Other provinces across Canada are working on developing screening programs also. In this podcast series, we discuss the importance of lung cancer screening and aim to raise awareness of these programs in Canada in order to improve patient care. Our Guests
    Dr. Donna Maziak: Thoracic surgeon and surgical oncologist at the Ottawa Hospital, Ottawa, Ontario.
      
    Chantal Bornais: Nurse navigator at the Ottawa Hospital, Ottawa, Ontario. 


    Resources
    Lakeridge Health in Oshawa: https://www.lakeridgehealth.on.ca/en/central-east-regional-cancer-program/lung-cancer-screening-pilot.asp
    The Ottawa Hospital: https://www.ottawahospital.on.ca/en/clinical-services/deptpgrmcs/programs/cancer-program/what-we-offer-our-programs-and-services/lung-screening/Health Sciences North in Sudbury: https://www.hsnsudbury.ca/portalen/rcp/hrlcspPrincess Margaret Hospital in Toronto: https://www.trcp.ca/en/screening/screening-programs/Pages/lung.aspxCancer Care Ontario: https://www.cancercareontario.ca/enTO FIND A SCREENING PROGRAM NEAR YOU: https://right2survive.ca/resource-centre/screening/
     If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.

    • 33 min
    Dépistage du Cancer Du Poumon: Québec

    Dépistage du Cancer Du Poumon: Québec

    Renseignements généraux
    Le cancer du poumon est l’une des formes de cancer les plus courantes ainsi que la principale cause de décès par cancer au Canada. (Statistiques canadiennes sur le cancer, 2020).Le taux de survie des patients atteints d’un cancer du poumon est faible. La survie nette à trois ans est de 71 % pour les cas diagnostiqués au stade 1, et chute à 5 % pour les cas diagnostiqués au stade 4. Au Canada, environ la moitié des cancers du poumon ont atteint le stade 4 au moment du diagnostic. (Statistiques canadiennes sur le cancer, 2020).Deux études cliniques, soit l’étude néerlando-belge sur le dépistage NELSON et une étude américaine nationale sur le dépistage du cancer du poumon (l’étude NLST), ont montré l’utilité du dépistage du cancer du poumon dans la réduction du taux de mortalité chez les populations à haut risque.Au Canada, il y a consensus au sein de la communauté du cancer du poumon quant à la nécessité de mettre en œuvre des programmes de dépistage à l’échelle nationale.On a annoncé la mise en œuvre de programmes de dépistage du cancer du poumon à l’échelle du Canada. L’Ontario et le Québec ont lancé les leurs en avril et en juin 2021, respectivement. La Colombie-Britannique a fait l’annonce de son programme en 2020; celui-ci sera lancé sous peu. D’autres provinces travaillent également à l’élaboration de programmes de dépistage. Dans cette série de balados, nous discuterons de l’importance du dépistage du cancer du poumon et des moyens de faire connaître ces programmes au Canada afin d’améliorer les soins offerts aux patients.Invités
    Dre Nicole Bouchard: Pneumologue au département de médecine de l’Université de Sherbrooke, Québec.

    Dr Richard Dumouchel:  Omnipraticien à la Clinique médicale du Coteau, à Saint-Jean-sur-Richelieu, Québec.

    Résources
    https://right2survive.ca/resource-centre/screening/
    https://www.quebec.ca/en/health/advice-and-prevention/screening-and-carrier-testing-offer/lung-cancer-screening-demonstration-project 
     If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.

    • 30 min
    Lung Cancer Screening: National

    Lung Cancer Screening: National

    Background
    Lung cancer is one of the most common cancers and is the leading cause of cancer death in Canada. (2020 Canadian Cancer Statistics) Survival from lung cancer is poor. Three-year net survival for lung cancer decreased from 71% among those diagnosed at stage 1 to 5% among those diagnosed at stage 4. Approximately half of all lung cancer cases in Canada are stage 4 at diagnosis. (2020 Canadian Cancer Statistics) Two clinical trials, the Dutch-Belgian screening trial (NELSON) and the United States National Lung Screening Trial (NLST), have demonstrated the value of lung cancer screening in reducing mortality rates in high-risk populations. The lung cancer community across Canada is therefore united in the belief that screening programs should be implemented nationwide. Lung Cancer Screening programs have been announced across Canada. The Ontario program launched in April 2021 and the program in Quebec launched in June 2021. A program in BC was announced in 2020 and will launch in the near future. Other provinces across Canada are working on developing screening programs also. In this podcast series, we discuss the importance of lung cancer screening and aim to raise awareness of these programs in Canada in order to improve patient care. Our Guests
    Dr. Paul Wheatley-Price: Associate Professor in the Department of Medicine at the University of Ottawa and Medical Oncologist at The Ottawa Hospital Cancer Centre, specializing in the treatment of thoracic malignancies and carcinoma of unknown primary. Since 2016, Dr. Wheatley-Price has previously served as President of Lung Cancer Canada. 
    Dr. Jeffery Habert: General practitioner in Thornhill, ON and Assistant Professor in the Department of Family and Community Medicine at the University of Toronto.

    Resources
    ONTARIO
    Lakeridge Health in Oshawa: https://www.lakeridgehealth.on.ca/en/central-east-regional-cancer-program/lung-cancer-screening-pilot.aspThe Ottawa Hospital: https://www.ottawahospital.on.ca/en/clinical-services/deptpgrmcs/programs/cancer-program/what-we-offer-our-programs-and-services/lung-screening/Health Sciences North in Sudbury: https://www.hsnsudbury.ca/portalen/rcp/hrlcspPrincess Margaret Hospital in Toronto: https://www.trcp.ca/en/screening/screening-programs/Pages/lung.aspxBRITISH COLUMBIA
    The BC Lung Screen Trial: http://www.bccancer.bc.ca/our-research/participate/lung-healthCPAC Report: https://s22457.pcdn.co/wp-content/uploads/2021/01/lung-cancer-screening-environmental-scan-2019-2020-Jan132021-EN.pdf
    TO FIND A SCREENING PROGRAM NEAR YOU: https://right2survive.ca/resource-centre/screening/
     If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.

    • 25 min
    Precision Medicine in Oncology: Ep.4 Access to Genomic Profiling in Quebec

    Precision Medicine in Oncology: Ep.4 Access to Genomic Profiling in Quebec

    In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:
    ·       The initiatives developed by Colorectal Cancer Canada to help progress access to genomic profiling and precision medicine for all cancer patients 
    ·       The patient’s perspective on education, access, and value of genomic profiling
    ·       Access to genomic profiling in Quebec
    ·       The value of IMPACT Medicom’s comprehensive genomic profiling prioritization report: https://www.impactmedicom.com/publications/reports
    Our guest:
    Barry D. Stein is the President and CEO of Colorectal Cancer Canada and is himself a survivor of metastatic colorectal cancer. He is an established lawyer in the fields of commercial and corporate law with GWBR, LLP in Montreal, where he dedicates a significant portion of his practice to labour law, as well as litigation in health and administrative law. Barry is the past president of the Coalition Priorité Cancer au Québec. He is also past chair of the IQVIA Advisory Council for the Advancement of Health in Quebec and a member of the Board of Directors of the Canadian Personalized Healthcare Innovation Network, EXACTIS Innovation, and the Quebec Clinical Research Organization in Cancer (Q-CROC).
     
     If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.

    • 33 min

Classement des podcasts dans Sciences